F3 and cancer: Tissue factor (24), von Willebrand factor (25), and ADP (26) have been deemed common metabolites contributing to stent thrombosis and cancer pathogenesis; therefore, one would naturally expect that heightened levels of these metabolites from cancer pathogenesis would delay stent healing by contributing to stent thrombosis.